Diagnostic Performance of a New Bio-marker During Bacterial Sepsis (BACTIDIAG)
Sponsor: Bio-Rad Laboratories
Listed as NCT02721134, this NA trial focuses on Sepsis and remains completed. Sponsored by Bio-Rad Laboratories, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Apr 2022 [monthly]
Unknown Status NA
-
Aug 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Aug 2018 — Aug 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bio-Rad Laboratories
- Centre Hospitalier Universitaire de Nice
For direct contact, visit the study record on ClinicalTrials.gov .